Observational study monitoring the effects of oral cabergoline on avoidance of symptoms of Ovarian Hyperstimulation Syndrome (OHSS) in patients at risk of ovarian hyperstimulation syndrome when undergoing an In-Vitro Fertilisation (IVF) cycle
Not Applicable
Completed
- Conditions
- Ovarian hyperstimulation syndrome (OHSS)Reproductive Health and Childbirth - Fertility including in vitro fertilisation
- Registration Number
- ACTRN12609000222246
- Lead Sponsor
- Fertility Specialists of Western Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Patients whose oestradiol level is >15,000 pmol/l, or more than 20 follicles on ultrasound examination prior to the day of HCG trigger
Exclusion Criteria
Patients with a significant concurrent medical illness or a contraindication to the administration of cabergoline.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method